PharmiNews

The Directory of Pharma Companies and News

Horizon Pharma

Horizon Pharma logo
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon Pharma's global headquarters are in Dublin, Ireland.
Category:
Category:
Keywords: orphan drugs,

Horizon Pharma News

DateNews
2016-12-22Horizon Pharma plc to Present at the 35th Annual J.P. Morgan Healthcare Conference
2016-12-22Horizon Pharma plc Announces Availability of QUINSAIR™ (levofloxacin inhalation solution) in Canada for the Treatment of...
2016-12-08Horizon Pharma plc to Participate in Investor Conference in December
2016-12-08Horizon Pharma plc Announces Topline Results from Phase 3 Study of  ACTIMMUNE® (interferon gamma-1b) in Friedreich's Ata...
2016-11-14Horizon Pharma plc Presents Data on KRYSTEXXA® (pegloticase) for the Management of Refractory Chronic Gout at the 2016 A...
2016-11-11Horizon Pharma plc Selected as One of Chicago Tribune's 2016 Top Workplaces
2016-11-07Horizon Pharma plc Announces Third-Quarter 2016 Financial Results
2016-11-04Horizon Pharma plc to Participate in Investor Conferences in November
2016-11-03Horizon Pharma plc Announces Availability of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in Canada
2016-09-12Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business
2016-09-06Horizon Pharma plc to Participate in Morgan Stanley Global Healthcare Conference
2016-08-08Horizon Pharma plc Announces Second-Quarter 2016 Financial Results
2016-07-07Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016
2016-06-29Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid to Exp...
2016-06-27Horizon Pharma plc Added to Russell 2000(R) and 3000(R) Indexes
2016-06-02Horizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference
2016-05-19Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH
2016-05-18Horizon Pharma plc to Participate in UBS Global Healthcare Conference
2016-05-12Horizon Pharma plc Announces That Marilyn Vetter Honored as a 2016 Healthcare Businesswomen's Association Luminary
2016-05-11Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of Allowance With Claims...
2016-05-09Horizon Pharma plc Announces First-Quarter 2016 Financial Results
2016-05-05Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) fo...
2016-05-04Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Three Additional Notices of Allowance With...
2016-05-03Horizon Pharma plc to Present at Two Investor Conferences in May
2016-04-25Horizon Pharma plc Announces Settlement of PENNSAID(R) (diclofenac sodium topical solution) 2% w/w Patent Litigation Wit...
2016-04-18Horizon Pharma plc to Host First-Quarter 2016 Conference Call and Webcast on May 9, 2016
2016-04-04Horizon Pharma plc Named to Crain's Chicago Business First Ever 2016 "Best Places To Work for Women Over 35" List
2016-03-21Horizon Pharma plc Receives Health Canada Approval for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid for the Treatmen...
2016-03-01Horizon Pharma plc to Participate in Cowen and Company 36th Annual Health Care Conference
2016-02-29Horizon Pharma plc Recognizes Rare Disease Community on the "Rarest Day of the Year"
2016-02-29Horizon Pharma plc Announces Record Fourth-Quarter and Full-Year 2015 Financial Results and Confirms Full-Year 2016 Sale...
2016-02-22Horizon Pharma plc Announces That Health Canada Determines RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid Is Eligible ...
2016-01-29Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016
2016-01-28Horizon Pharma plc to Participate in Three Investor Conferences in February
2016-01-14Horizon Pharma plc Completes Acquisition of Crealta Holdings LLC
2016-01-12Horizon Pharma plc Raises Full-Year 2016 Net Sales and Adjusted EBITDA Guidance Based on Expected Close of the Crealta H...
2015-12-17Horizon Pharma plc to Present at the 34th Annual J.P. Morgan Healthcare Conference
2015-12-14Horizon Pharma plc and Fox Chase Cancer Center Temple Health Initiate Phase 1 Study to Evaluate ACTIMMUNE(R) (interferon...
2015-12-11Horizon Pharma plc to Acquire Crealta Holdings LLC in All Cash Acquisition
2015-11-30Horizon Pharma plc Receives European Commission Approval for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid for the Tr...
2015-11-20Horizon Pharma plc Withdraws Offer to Acquire Depomed, Inc.
2015-11-19Horizon Pharma plc to Present at Two Conferences in December
2015-11-13Horizon Pharma plc Selected as One of Chicago Tribune's Top Workplaces in 2015
2015-11-13Horizon Pharma plc Provides Update on Shareholders Meeting Related to the Proposed Acquisition of Depomed, Inc.
2015-11-11Horizon Pharma plc Responds to Express Scripts Lawsuit and Recent Allegations
2015-11-11Horizon Pharma plc Provides Comment on Express Scripts' Business Practices
2015-11-11Horizon Pharma plc Announces Collaboration With Alliance for Lupus Research to Study RAYOS(R) (prednisone) Delayed-Relea...
2015-11-09Horizon Pharma plc Announces 2016 Net Sales and Adjusted EBITDA Guidance; Reviews 2020 Long-Range Plan
2015-11-06Horizon Pharma plc Announces Exceptional Third-Quarter 2015 Financial Results and Significantly Raises Full-Year 2015 Sa...
2015-11-05Horizon Pharma plc Announces Clinical Data to Be Presented at the 2015 ACR/ARHP Annual Meeting
2015-11-04Horizon Pharma plc to Present at Three Conferences in November
2015-11-02Horizon Pharma plc to Host Investor Day on November 9, 2015
2015-10-26Horizon Pharma plc Extends Offer to Acquire Depomed, Inc.
2015-10-22Horizon Pharma plc Corrects Misinformation in the Marketplace
2015-10-21Horizon Pharma plc Announces Favorable Markman Ruling in RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid Patent Infring...
2015-10-21Horizon Pharma plc Provides Update on Relationship With Specialty Pharmacies
2015-10-16Horizon Pharma plc to Host Third Quarter 2015 Conference Call and Webcast on November 6, 2015
2015-10-15Horizon Pharma plc Files Definitive Proxy Statement for Extraordinary General Meeting of Horizon Pharma Shareholders
2015-10-13Horizon Pharma plc Files Preliminary Proxy Materials for Special Meetings
2015-10-09Horizon Pharma plc Chairman and Chief Executive Officer Timothy P. Walbert Inducted Into Chicago Area Entrepreneurship H...
2015-10-07Horizon Pharma plc Announces That Three of the Leading Proxy Advisory Firms Recommend That Depomed Shareholders Provide ...
2015-10-05Horizon Pharma plc Announces Expansion and Relocation of U.S. Corporate Headquarters
2015-10-02Horizon Pharma plc Announces Settlement of RAYOS(R) (prednisone) Delayed-Release Tablets Patent Litigation With Actavis ...
2015-09-29Horizon Pharma plc Announces Leading Proxy Advisory Service, Glass Lewis & Co., Recommends Depomed Shareholders Provide ...
2015-09-28Institutional Shareholder Services (ISS) Recommends Depomed Shareholders Provide Consent FOR the Two Special Meeting Req...
2015-09-25Horizon Pharma plc Receives Positive CHMP Opinion for RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid for the Treatment...
2015-09-10Horizon Pharma plc Has Commenced Solicitation of Depomed, Inc. Shareholders for Calling of Special Meetings
2015-09-09Horizon Pharma plc to Present at the Morgan Stanley Global Healthcare Conference
2015-09-08Horizon Pharma plc Commences Exchange Offer to Acquire All Depomed, Inc. Common Shares
2015-08-19Horizon Pharma plc to Amend Preliminary Solicitation Statement to Include Proposed Nominees for Depomed's Board
2015-08-13Horizon Pharma plc Sends Letter to Depomed, Inc Board of Directors
2015-08-07Horizon Pharma plc Announces Record Second Quarter 2015 Financial Results
2015-08-07Horizon Pharma plc Names George Hampton Executive Vice President, Global Orphan Business Unit and International Operatio...
2015-08-03Horizon Pharma plc Commences Process to Request a Special Meeting of Depomed, Inc. Shareholders
2015-07-27Horizon Pharma plc Announces Collaboration With Fox Chase Cancer Center to Study ACTIMMUNE(R) (interferon gamma-1b) in C...
2015-07-21Horizon Pharma plc Increases Offer for Depomed, Inc. to $33.00 per Share
2015-07-20Horizon Pharma plc Expects Record Net Sales Results for Second Quarter 2015 and Raises Full-Year 2015 Net Sales and Adju...
2015-07-13Horizon Pharma plc Responds to Depomed's Adoption of a Poison Pill
2015-07-09Horizon Pharma plc Names Tina E. Ventura Vice President, Investor Relations
2015-07-07Horizon Pharma plc Proposes to Acquire Depomed, Inc. for $29.25 per Share in an All-Stock Transaction, Representing a 42...
2015-07-06Horizon Pharma plc Files Patent Infringement Lawsuits Against Five Companies for Filing Abbreviated New Drug Application...
2015-07-02Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Cla...
2015-06-19Timothy P. Walbert Receives EY Entrepreneur Of The Year(R) 2015 Midwest Award
2015-06-16Horizon Pharma plc Updates Presentation Time at the JMP Securities 2015 Life Sciences Conference
2015-06-05Horizon Pharma plc Initiates Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) for the Treatment of People With Friedr...
2015-05-21Horizon Pharma plc to Participate in Two Conferences in June
2015-05-14Horizon Pharma plc Announces That Amy Grahn Honored as a 2015 Healthcare Businesswomen's Association Luminary
2015-05-08Horizon Pharma plc Announces First Quarter 2015 Financial Results and Increases 2015 Guidance
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.